JSP Pharmaceutical Manufacturing Public Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 05:38 am
Share
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was THB 106.28 million compared to THB 107.24 million a year ago. Net loss was THB 4.71 million compared to net income of THB 6.32 million a year ago. Basic loss per share from continuing operations was THB 0.01 compared to basic earnings per share from continuing operations of THB 0.02 a year ago. Diluted loss per share from continuing operations was THB 0.01 compared to diluted earnings per share from continuing operations of THB 0.02 a year ago.
For the nine months, revenue was THB 291.41 million compared to THB 316.78 million a year ago. Net loss was THB 28.14 million compared to net income of THB 25.69 million a year ago. Basic loss per share from continuing operations was THB 0.06 compared to basic earnings per share from continuing operations of THB 0.08 a year ago. Diluted loss per share from continuing operations was THB 0.06 compared to diluted earnings per share from continuing operations of THB 0.08 a year ago.
JSP Pharmaceutical Manufacturing (Thailand) PCL is a Thailand-based company, which manufactures and distributes conventional medicines. The Company manufactures and distributes products under customerâs brand name (OEM), as well as under the Companyâs brand name. The Company develops, manufactures and sells conventional and traditional medicines, herbal products and dietary supplements, providing a range of services covering the manufacturer and the seller of the products under both customersâ trademark (OEM) and the seller of the products under the Companyâs trademark (Own Brand). The Company develops herbal products, dietary supplements with natural extracts and plant-based protein under brand name Supap Osot, and dietary supplements such as using new raw materials or having new production process for both beauty and health under brand name EVITON. The Companyâs subsidiary, Caresutic Co., Ltd., is engaged in manufacturing and distribution of dietary supplements and cosmetic products.